泪液炎性细胞因子分析与糖尿病及非糖尿病干眼症临床相关性研究
该横断面研究纳入糖尿病伴干眼症32例、糖尿病不伴干眼症24例、非糖尿病伴干眼症28例及正常志愿者29例,检测泪液EGF、IL-17A、IL-1β和TNF-α浓度并分析其与眼表参数的相关性。结果显示糖尿病伴干眼症组泪液EGF显著升高且与CFS正相关、与Schirmer I试验负相关,而非糖尿病伴干眼症组IL-17A、IL-1β和TNF-α升高且IL-1β和TNF-α与CFS正相关。结论提示泪液EGF有望成为糖尿病干眼症的诊断生物标志物,糖尿病干眼症与非糖尿病干眼症发病机制可能不同。
要点
- 糖尿病干眼症组泪液EGF显著升高,与CFS正相关、与Schirmer I试验负相关。
- 糖尿病干眼症组IL-17A、IL-1β和TNF-α与正常组无差异。
- 非糖尿病干眼症组IL-17A、IL-1β和TNF-α升高,IL-1β和TNF-α与CFS正相关。
核心结论
- 泪液EGF有望作为糖尿病干眼症的诊断生物标志物。
- 糖尿病干眼症与非糖尿病干眼症发病机制可能不同。
研究设计与样本
- 横断面研究,分为糖尿病伴干眼症组32例、糖尿病不伴干眼症组24例、非糖尿病伴干眼症组28例和正常组29例。
- 评估OSDI、BUT、Schirmer I试验、CFS和角膜敏感性,采用multiplex bead analysis检测泪液EGF、IL-17A、IL-1β和TNF-α浓度。
- 采用Spearman相关分析细胞因子与眼表参数的相关性。
主要发现
- 糖尿病伴干眼症组泪液EGF水平显著升高,且与CFS正相关、与Schirmer I试验负相关(P < .05)。
- 糖尿病伴干眼症组和糖尿病不伴干眼症组泪液IL-17A、IL-1β和TNF-α水平与正常组相比无差异(P > .05)。
- 非糖尿病伴干眼症组泪液IL-17A、IL-1β和TNF-α水平较正常组升高,且IL-1β和TNF-α与CFS正相关(P < .05)。
临床怎么用
- 糖尿病干眼症患者可考虑检测泪液EGF辅助诊断。
- 糖尿病与非糖尿病干眼症的眼表炎症机制不同,治疗策略可能需区别对待。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To enhance the understanding of dry eye (DE) in diabetes by evaluating the ocular surface characteristics and the levels of tear inflammatory cytokines. DESIGN: Cross-sectional study. METHODS: Subjects were divided into 4 groups: 32 patients in the diabetes with DE group; 24 patients in the diabetes without DE group; 28 patients in the nondiabetes with DE group; and 29 volunteers in the normal group. Ocular surface disease index (OSDI) was self-answered and ocular surface characteristics including tear film break-up time (BUT), Schirmer I test, corneal fluorescein staining (CFS), and corneal sensitivity were evaluated. Concentrations of epidermal growth factor (EGF), IL-17A, IL-1β, and tumor necrosis factor alpha (TNF-α) were measured by mutiplex bead analysis. Spearman correlations between cytokines and ocular surface parameters were calculated. RESULTS: The level of EGF in tears significantly increased in the diabetes with DE group and positively correlated with the CFS and negatively correlated with the Schirmer I test in this group (P < .05). No differences were found in the levels of IL-17A, IL-1β, and TNF-α in the diabetes with DE and diabetes without DE groups compared to the normal group (P > .05). The nondiabetes with DE group showed increased levels of IL-17A, IL-1β, and TNF-α in tears compared to the normal group and the levels of IL-1β and TNF-α in tears positively correlated with CFS (P < .05). CONCLUSIONS: Our study showed that levels of EGF in tears have potential to be the diagnostic biomarker of DE in diabetes. No differences of IL-17A, IL-1β, and TNF-α in tears were found between the diabetes with DE and normal group, suggesting different pathogenesis of diabetes DE vs nondiabetes DE.
引用
- Liu R, Ma B, Gao Y, et al. Tear Inflammatory Cytokines Analysis and Clinical Correlations in Diabetes and Nondiabetes With Dry Eye. Am J Ophthalmol. 2018. PMID: 30552892. doi:10.1016/j.ajo.2018.12.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。